Stay updated on 89Zr-Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 89Zr-Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a Locations section featuring North Holland (Amsterdam, Netherlands) and removed the old North Holland Locations entry; the HHS Vulnerability Disclosure link was removed. The footer now shows Revision: v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:09:21.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:00.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Removed the general government funding/operating status notice from the page; no study details or trial data appear to be affected.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:54.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The new design reorganizes sections and adjusts visuals while core study details (title, conditions, interventions, eligibility criteria, primary/secondary outcomes, and enrollment) remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:22:57.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government-operating-status notice; the previous v3.1.0 reference has been removed.
    Difference
    3%
    Check dated 2025-10-06T06:34:05.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:30.000Z thumbnail image

Stay in the know with updates to 89Zr-Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.